Antibody therapy for rheumatoid arthritis.
High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...
Príomhchruthaitheoir: | Taylor, P |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2003
|
Míreanna comhchosúla
-
Humanised monoclonal antibody therapy for rheumatoid arthritis.
de réir: Isaacs, J, et al.
Foilsithe / Cruthaithe: (1992) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
de réir: Isaacs, J, et al.
Foilsithe / Cruthaithe: (1992) -
Anti-cytokine therapy for rheumatoid arthritis.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (2000) -
Anti-TNFalpha therapy for rheumatoid arthritis: an update.
de réir: Taylor, P
Foilsithe / Cruthaithe: (2003) -
Antikeratin antibodies in rheumatoid arthritis
de réir: J Zabek
Foilsithe / Cruthaithe: (2003-02-01)